Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
June 21, 2022
Biologic use and outcomes among adults with severe asthma treated by US subspecialists
Reynold A Panettieri, Dennis K Ledford, Bradley E Chipps, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 19, 2020
Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma
Wendy C Moore, Reynold A Panettieri, Jennifer Trevor, et al.
The Journal of Allergy and Clinical Immunology
|
April 13, 2011
Differences in recommendations between the Allergic Rhinitis and its Impact on Asthma Update 2010 and US Rhinitis Practice Parameters
Bradley Chipps, Sheldon Spector, Judith Farrar, et al.
Expert Opinion on Pharmacotherapy
|
March 10, 2015
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps
Jean Bousquet, Claus Bachert, Jonathan Bernstein, et al.
International Archives of Allergy and Immunology
|
May 9, 2013
Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis
Eli Meltzer, Paul Ratner, Claus Bachert, et al.
Pharmacoepidemiology and Drug Safety
|
October 23, 2021
Response to letter to the editor regarding "Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data"
Daniel C Beachler, Devon H Taylor, Mary S Anthony, et al.
Pharmacoepidemiology and Drug Safety
|
April 26, 2021
Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data
Daniel C Beachler, Devon H Taylor, Mary S Anthony, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
January 6, 2015
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants
Thomas Luger, Mark Boguniewicz, Warner Carr, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
July 13, 2018
Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS
Anne-Lise Courbis, Ruth Brigid Murray, Sylvie Arnavielhe, et al.
Allergy
|
December 20, 2018
ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project
Sinthia Bosnic-Anticevich, Elisio Costa, Enrica Menditto, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
June 21, 2022
Biologic use and outcomes among adults with severe asthma treated by US subspecialists
Reynold A Panettieri, Dennis K Ledford, Bradley E Chipps, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 19, 2020
Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma
Wendy C Moore, Reynold A Panettieri, Jennifer Trevor, et al.
The Journal of Allergy and Clinical Immunology
|
April 13, 2011
Differences in recommendations between the Allergic Rhinitis and its Impact on Asthma Update 2010 and US Rhinitis Practice Parameters
Bradley Chipps, Sheldon Spector, Judith Farrar, et al.
Expert Opinion on Pharmacotherapy
|
March 10, 2015
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps
Jean Bousquet, Claus Bachert, Jonathan Bernstein, et al.
International Archives of Allergy and Immunology
|
May 9, 2013
Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis
Eli Meltzer, Paul Ratner, Claus Bachert, et al.
Pharmacoepidemiology and Drug Safety
|
October 23, 2021
Response to letter to the editor regarding "Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data"
Daniel C Beachler, Devon H Taylor, Mary S Anthony, et al.
Pharmacoepidemiology and Drug Safety
|
April 26, 2021
Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data
Daniel C Beachler, Devon H Taylor, Mary S Anthony, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
January 6, 2015
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants
Thomas Luger, Mark Boguniewicz, Warner Carr, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
July 13, 2018
Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS
Anne-Lise Courbis, Ruth Brigid Murray, Sylvie Arnavielhe, et al.
Allergy
|
December 20, 2018
ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project
Sinthia Bosnic-Anticevich, Elisio Costa, Enrica Menditto, et al.
Page
of 4